Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Prazer Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Prazer Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.